$掌门教育(ZME.US)$ Hurry up and run. A large number of employees at the head of education in Beijing have been dismissed; there are only a few people left at the headquarters.

$Brooklyn ImmunoTherapeutics Inc(BTX.US)$ 现在上车还来得及！

$Brooklyn ImmunoTherapeutics Inc(BTX.US)$
Brooklyn ImmunoTherapeutics said on Monday that it has signed a letter of intent to acquire Novellus Therapeutics, a company developing mesenchymal stem cell therapy. The two companies said they intend to sign an agreement and work to complete the acquisition by July 15. The letter of intent valued Novellus at $125 million, and Brooklyn proposed payment through a combination of $17.4 million in cash and $1076 million in common stock. Brooklyn said it has more than $43 million in cash on its balance sheet to fund the cash portion of the deal.

$Brooklyn ImmunoTherapeutics Inc(BTX.US)$
Brooklyn Immunotherapy Inc. - On April 26, 2021, the company signed a purchase agreement with Lincoln Park Capital Fund LLC or Lincoln Park
Brooklyn Immunotherapy Company - On April 26, 2021, the company signed a purchase agreement with Lincoln Park Capital Fund LLC or Lincoln Park
BROOKLYN IMMIOTHERAPEUTICS - signed a purchase agreement under which CO can sell up to $20.0 million in common stock to Lincoln Park
BROOKLYN IMMIOTHERAPEUTICS - Under a registration rights agreement with Lincoln Park, CO agreed to file a registration statement with the SEC
Brooklyn Immunotherapy - On April 26, 2021, UNIT signed licensing agreements with FACTOR BIOSCIENCE LIMITED and NOVELLUS THERAPEUTICS LIMITED

$WISeKey(WKEY.US)$
WISeKey completes arago's AI function with its semiconductor manufacturing integrated WISeKey VaultIC security components and security microcontrollers protect a wide range of Internet of things devices and consumer products that generate large amounts of trusted data needed for automated AI purposes. WISeKey's Swiss Internet of things Security, together with German artificial intelligence leader arago, combines artificial intelligence, Internet of things and network security into a trusted European Internet of things platform. Geneva, Switzerland-June 7, 2021: WISeKey International Holdings Limited ("WISeKey"), the world's leading cyber security and Internet of things company (6: WIHN, NASDAQ: WKEY), today announced that it has completed the integration of arago's artificial intelligence functions with its semiconductor manufacturing industry. This combination is powerful because artificial intelligence allows semiconductor companies to get 40% to 50% of the total value from the technology stack, the best opportunity they have in decades. Storage will experience the highest growth, but semiconductor companies will get the most value in computing, memory and networking. Carlos Moreira (Carlos Moreira), founder and CEO of WISeKey, said: "WISeKey has been selected by global companies as their digital trust partner. "our semiconductors are widely used in many sensitive applications that not only require unique technical expertise, but also.

$COLOR STAR TECHNOLOGY CO LTD(CSCW.US)$ 1.11
Color Star Technology Co., Ltd. (Nasdaq CM: CSCW) is an entertainment and education company that provides online entertainment and online music education services. Its business operations are carried out through its wholly-owned subsidiaries Color China Entertainment Ltd., and CACM Group NY, Inc. The company's online education is delivered through its Color World music and entertainment education platform.
Basil Wilson, Co-CEO of Color Star, commented: “Being selected for the Russell Micro Market Capitalization Index® is a significant achievement for Color Star. This is proof of the significant progress we have made as a company. We are confident that member Russel Microcap Index will provide further visibility and greater liquidity for our shares in the financial community. We look forward to bringing a wider audience of investors to our platform and growth story, and continuing to execute our strategy in the second half of the year with several important milestones this year, which further propel us on the path to long-term value creation.” An index based on FTSE Russell, the world's leading index provider, is widely used by investment managers and institutional investors in index funds; it is a tool for measuring active investment strategies. Approximately $9 trillion in assets is based on the Russell US Index. Becoming a member of the famous Russell Index® has many benefits, including automatically inserting the appropriate growth and value style indices. This inclusiveness will remain for a year...

$WISeKey(WKEY.US)$ 8.27
WISeKey (NASDAQ: WKEY;SIX Swiss Exchange:WIHN), a leading global cyber security company, is currently using blockchain, artificial intelligence and the Internet of things to deploy a large-scale digital identity ecosystem for people and objects. Respect for people is the fulcrum of the Internet. WISeKey microprocessors provide security for shaping the pervasive computing of the Internet of everything today. WISeKey IoT has more than 1.5 billion microchips installed in almost all areas of the Internet of things (connected cars, smart cities, drones, agricultural sensors, security, intelligent lighting, servers, computers, mobile phones, encryption tokens, etc.). WISeKey is in a unique position at the edge of the Internet of things because our semiconductors produce a large number of big data, and when using artificial intelligence (AI) for analysis, it can help industrial applications predict equipment failures before they occur.
WISeKey International Holdings Limited announced a new research and development partnership with MINES Saint-Etienne Research Institute ("MINES Saint-Etienne-Etienne"), an internationally renowned multidisciplinary university and laboratory established in 1816, to help the international community find cryptographic algorithms that can withstand future quantum computing-based cyber attacks. They will jointly participate in the relevant National Institute of Standards and Technology (NIST) standardization program (NIST PQC) launched in 2016. About quantum computing.

$Brooklyn ImmunoTherapeutics Inc(BTX.US)$ 14.75
Headquartered in Brooklyn, New York, USA, is a biopharmaceutical company focused on exploring the role of cytokine and gene editing/cell therapy in treating cancer patients, blood diseases, and monogene diseases. He has just hired Kevin A. D'Amour as the chief scientist with a salary of 410,000 US dollars a year, PhD at the University of California, age 48. Kevin A. D'Amour has previously been Chief Scientist at Viacyte, Inc., a private clinical stage company developing stem cell-based therapies for type 1 and insulin-dependent type 2 diabetes mellitus, most recently as the company's chief scientific officer. With over 100 U.S. and international patents, his significant experience in early to clinical success in cell and gene modified cell therapy makes him a great fit for Brooklyn, as we are working on what we believe will be pioneering work in multiple application areas, many of which are currently “There are no treatments available,” said Howard J. Federoff, MD, CEO and President of Brooklyn. “We look forward to moving our work forward under Kevin's leadership, and we welcome him to Brooklyn.” Brooklyn's exclusive access to Factor Bioscience and Novellus technologies for mRNa-based gene editing and cell reprogramming, combined with the new mRNA delivery system, provides a powerful technology platform and a myriad of compelling treatments. I look forward to helping successfully apply these methods to...